Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Pediatr Pulmonol. 2015 Apr 7;50(12):1270–1276. doi: 10.1002/ppul.23180

Table 2.

Demographics, immunohistochemistry for MUC5B, and MUC5B genotype. “AEII” represents cells morphologically consistent with alveolar epithelial type II cells. Genotype is for the MUC5B promoter variant. GG = wildtype genotype and GT = heterozygous for the variant. (Note: patients 2, 4, and 6 correspond to patients 11, 15, and 12, respectively in Table 1)

Patient # Age at biopsy Disease state Mutation Interstitial Fibrosis Brichos MUC5B in “AEII” Genotype
1 2 months SPC G182R no yes yes GG
2 2 months SPC c460+1G>A no yes yes GG
3 3 months SPC 100Glu->Val and 103Leu->Val no no no GT
4 5 months SPC 140delA no yes yes GG
5 16 months SPC I73T no no no GG
6 22 months SPC L188Q L->A yes yes yes GT
7 21 days ABCA3 no no GG
8 2 months ABCA3 no no GG
9 16 days ABCA3 no no GG
10 15 months control no no GG
11 5 months control no no GG
12 11 months control no no GG
13 23 months control no no GG
14 3 months control no no GG
15 7 months control no no GG

SPC = patients with SFTPC mutations, ABCA3 = patients with ABCA3 mutations